High-Risk PCI Involving Chronic Kidney Disease, PVD and LV-dysfunction
Dr. Flaherty presents a case review of an 85-year-old male who presented with unstable angina symptoms, multivessel coronary ar...
Bleeding & Vascular Complications Data Sheet
Overview of Bleeding Rate Improvement with Impella® IMP-1041...
Impella Protects Against AKI in HRPCI
With Impella support in high-risk PCI, overall incidence of post-procedural AKI is significantly re...
WellStar Hub and Spoke Cardiogenic Shock Treatment Network
Successful Implementation of Cardiogenic Shock Algorithm Dr. Salvatore Mannino discusses the...
Largest FDA Study of High-Risk PCI Patients Shows Improved Outcomes with Impella® Heart Pumps
Jeffrey J. Popma, MD, presents the latest data from the PROTECT series clinical study...
Impella Patient Systemic IV Heparin Rate Calculator
Anticoagulation Therapy with Impella® Heparin Infusion...
Cardiogenic Shock Protocol Pocket Guide
Using a defined cardiogenic shock best practices protocol derived from real-world data for...
Allegheny Health Network Protected PCI Algorithm
Download the Allegheny Health Network Protected PCI Algorithm to guide decision-making for appropriate use of the Impella® hea...
New Data from NCSI Demonstrates 72% Survival with 98% Native Heart Recovery
New data from the National Cardiogenic Shock Initiative Study (NCSI) on 171 consecutive AMI cardiogenic shock (AMICS) patients...
2019 Professional Education Brochure
Committed to improving outcomes in Cardiogenic Shock and Protected PCI through excellence in education....
Hub-Spoke Patient Transfer Packet
Use this patient transfer checklist and documentation when transferring a patient supported with an Impella® device from the...
Impella RP® Heart Pump Patient Selection Criteria Checklist
Use this checklist to guide treatment decisions and determine if the Impella RP is right for your patients. IMP-796...
Impella Updates – Reaccess Sheath
This sheath enables reaccess to the artery for the duration of Impella support with up to an 0.035” guidewire. The additional...
Renal Effects of Impella Support During Protected PCI
Dr. Michael P. Flaherty's TCT 2018 presentation on Renal Effects of Impella support during Protected PCI....
Analysis of Outcomes for 15,259 U.S. Patients with AMICS Supported with the Impella Device
Dr. William O’Neill outlines his recent publication of 15,529 AMI cardiogenic shock patients from the Impella Quality (IQ) da...
Step-by-Step Guide to Left Heart Unloading with Impella 5.0®
The Impella 5.0 is approved for use in cardiogenic shock, and is proven to unload the left ventricle and support the systemic c...
Step-by-Step Guide to Left Heart Unloading with Impella LD®
For patients in post cardiotomy cardiogenic shock (PCCS), the Impella LD can assist in the efforts to successfully unload the l...
Mt. Sinai Protected PCI Algorithm
Download the Mt. Sinai Protected PCI Algorithm to guide decision-making for appropriate use of the Impella 2.5 and Impella CP h...
Impella Quick Reference and Troubleshooting Guide
Impella 2.5/Impella CP/Impella 5.0/Impella LD/Impella RP Heart Pumps - Quick Reference and Troubleshooting Guide For AIC Softwa...
Complex PCI with Multiple Comorbidities
Dr. Tanveer Rab of Emory University joins Dr. Cathy Jeon to discuss a case of an 80 year old male with a low ejection fraction...
Henry Ford Algorithm
This is a sample high-risk PCI algorithm used by Henry Ford Health System. Specifically, it is a Left Ventricular Mechanical Ci...
INOVA Heart and Vascular Institute Protected PCI Algorithm
Download INOVA Heart and Vascular Institute’s Protected PCI algorithm, which begins with a heart team evaluation of high risk...
Clinical Dossier Protected PCI with Impella®
On March 23, 2015, the Impella 2.5™ received PMA approval from the U.S. FDA* and on December 2, 2016 the Impella CP® r...
Cardiogenic Shock Clinical Dossier
Impella 2.5®, Impella CP®, Impella 5.0®, and Impella LD® heart pumps are now ...
